157 studies found for:    Open Studies | "Vomiting"
Show Display Options
Rank Status Study
21 Unknown  Continuous Infusion of Palonosetron for Preventing of Postoperative Nausea and Vomiting
Condition: Postoperative Nausea and Vomiting
Interventions: Drug: continuous infusion of palonosetron added to prophylactic single injection of palonosetron;   Drug: continuous infusion of normal saline added to prophylactic single injection of palonosetron
22 Recruiting Dexamethasone and Ondansetron Versus Placebo for Postoperative Nausea and Vomiting
Condition: Postoperative Nausea and Vomiting
Interventions: Drug: Dexamethasone and Ondansetron;   Drug: Placebo
23 Recruiting Ondansetron Administration to Children With Gastroenteritis, Vomiting and SOME Dehydration in EDs in Pakistan
Conditions: Dehydration;   Gastroenteritis;   Vomiting;   Diarrhea
Interventions: Drug: Ondansetron;   Drug: Placebo
24 Unknown  Utility of Acupuncture in the Treatment of Postoperative Nausea and Vomiting in Ambulatory Surgery
Condition: Postoperative Nausea and Vomiting
Intervention: Other: Ear  seeds
25 Not yet recruiting Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Vitrectomy Under Local Anesthesia
Condition: Postoperative Nausea and Vomiting
Interventions: Drug: PLACEBO;   Drug: Dexamethasone;   Drug: Ondansetron;   Drug: Dexamethasone + Ondansetron
26 Recruiting Genetic Analysis of Children With Cyclic Vomiting Syndrome (CVS) and Migraines
Conditions: Vomiting Syndrome;   Migraines
Intervention:
27 Recruiting Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy
Conditions: Breast Cancer;   Nausea;   Vomiting
Interventions: Drug: granisetron transdermal system;   Drug: fosaprepitant dimeglumine;   Other: laboratory biomarker analysis
28 Unknown  Aprepitant for Prevention of Acute and Delayed Nausea and Vomiting in Patients Receiving a High-emetogenic Dose of Cyclophosphamide for Peripheral Blood Stem Cells Harvesting
Conditions: Nausea;   Vomiting
Interventions: Drug: Aprepitant, Palonosetron, Dexamethasone;   Drug: Placebo, Palonosetron, Dexamethasone
29 Recruiting A Single Dose of Intravenous (IV) Acetaminophen Verses Placebo in the Pre-operative Setting and Outcomes on Post-operative Pain, Nausea and Vomiting
Conditions: Post Operative Pain;   Post Operative Nausea and Vomiting
Interventions: Drug: IV acetaminophen;   Drug: placebo
30 Recruiting Study of Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)for Treatment of Post Operative Nausea and Vomiting
Conditions: Nausea;   Vomiting
Interventions: Drug: Trimebutine Maleate (NEWBUTIN SR 300 mg Tab);   Drug: Metoclopramide hydrochloride monohydrate
31 Recruiting Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy
Conditions: Hematopoietic/Lymphoid Cancer;   Nausea and Vomiting;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: Olanzapine;   Drug: Chemotherapy (cisplatin or cyclophosphamide and doxorubicin);   Drug: Antiemetic treatment (ondansetron or granisetron or palonosetron; plus dexamethasone; plus fosaprepitant or aprepitant);   Other: Placebo
32 Unknown  Dexamethasone for the Prevention of Post-operative Nausea and Vomiting in Patients Undergoing Cesarean Sections
Condition: Postoperative Nausea and Vomiting
Interventions: Drug: Dexamethasone;   Drug: Placebo
33 Unknown  Efficacy and Safety Evaluation of Carbamazepine for Prevention of Chemotherapy-induced Nausea and Vomiting
Condition: Chemotherapy-induced Nausea and Vomiting
Intervention: Drug: Carbamazepine
34 Recruiting Efficacy of Ginger as an Adjunctive Prophylaxis for Chemotherapy-induced Nausea and Vomiting
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Drug: Ginger;   Drug: Placebo
35 Recruiting Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients
Condition: Chemotherapy-induced Nausea and Vomiting
Intervention: Drug: Palonosetron, ondansetron, dexamethasone
36 Recruiting Fosaprepitant for Nausea and Vomiting During High-dose Interleukin-2 (HD IL-2) for Metastatic Melanoma and Renal Cell Carcinoma
Condition: Chemotherapy-induced Nausea and Vomiting
Intervention: Drug: Fosaprepitant
37 Recruiting Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children (MK-0517-029)
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Drug: Fosaprepitant 150 mg;   Drug: Fosaprepitant  60 mg;   Drug: Fosaprepitant  20 mg;   Drug: Placebo Fosaprepitant;   Drug: Ondansetron
38 Recruiting Neurokinin Receptor Antagonist Associated to Ondansetron in PONV
Condition: Postoperative Nausea and Vomiting
Intervention: Drug: Aprepitant
39 Unknown  Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nausea and Vomiting) Associated With the Administration of MEC (Moderately Emetogenic Chemotherapy)
Condition: Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV)
Interventions: Drug: Sancuso patch;   Drug: Kytril inj.+Kytril tab.
40 Unknown  Comparison of Adding EMEND to PONV/PDNV Treatment Regimen
Condition: Postoperative Nausea and Vomiting
Intervention: Drug: aprepitant

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years